VAKSX Mutual Fund

VAKSX Mutual Fund

NAV$10.21

Fund Essentials - as of Mar 31, 2026

Net Assets
$323,490.87
Expense Ratio
1.20%
Dividend Yield (Current)
-
Holdings
28
Inception Date
Dec 8, 2020
Fund Family
Virtus Investment Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD-0.69%
1 Year-9.61%
3 Year+2.03%
5 Year-1.93%

Asset Allocation

Stocks: 99.16%
Cash: 0.83%

Top Holdings

View All →
TickerNameWeight
LMATLemaitre Vascular Inc5.91%
HEI.AHeico Corp. Cl. A4.92%
WSTWest Pharmaceutical Services Inc4.92%
TDYTeledyne Technologies Inc4.86%
HQYHealthequity Inc4.31%
Top 10 Concentration: 44.02%Report Date: Mar 31, 2026
Download all 28 holdings for VAKSX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
FundXLS Pro
See how VAKSX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
X-ray my whole portfolio$45/quarter Pro · Cancel anytime
From MarketXLS, trusted since 2014.

VAKSX Mutual Fund Overview

VAKSX Mutual Fund (Virtus KAR Small-Mid Cap Growth Fund Class A) is managed by Virtus Investment Partners with $323,490.87 in net assets. VAKSX expense ratio is 1.20%, holding 28 positions across sectors including Industrials, Information Technology, Health Care. Inception date: 2020-12-08.

VAKSX performance shows a YTD return of -0.69%. The 1-year return is -9.61% and the 5-year return is -1.93%.

VAKSX top holdings include Lemaitre Vascular Inc (5.9%), Heico Corp. Cl. A (4.9%), West Pharmaceutical Services Inc (4.9%), Teledyne Technologies Inc (4.9%), Healthequity Inc (4.3%). Go to all VAKSX holdings, VAKSX sectors, or VAKSX dividends.

VAKSX can be compared against other funds. Use VAKSX overlap to find shared positions, or VAKSX vs another fund for a side-by-side view. VAKSX alternatives are available via the screener, along with tax-loss harvesting opportunities.